Avanos Medical, Inc. (AVNS)

Market Cap	634.77M -9.5%
Revenue (ttm)	701.20M +1.9%
Net Income	-72.90M
EPS	-1.57
Shares Out	46.50M
PE Ratio	n/a
Forward PE	13.65
Dividend	n/a
Ex-Dividend Date	n/a

Volume	369,179
Open	13.57
Previous Close	13.40
Day's Range	13.30 - 13.78
52-Week Range	9.30 - 15.68
Beta	1.09
Analysts	n/a
Price Target	n/a
Earnings Date	May 5, 2026

About AVNS

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2014
• Employees: 2,287
• Stock Exchange: NYSE
• Ticker Symbol: AVNS
• Website: https://avanos.com

Financial Performance

In 2025, Avanos Medical's revenue was $701.20 million, an increase of 1.95% compared to the previous year's $687.80 million. Losses were -$72.90 million, -81.41% less than in 2024.